Marques, Tiago Reis
King's College London · South London and Maudsley NHS Foundation Trust · Hammersmith Hospital · MRC London Institute of Medical Sciences · Imperial College London
13 papers on CoChatORCID 0000-0003-0602-7661
Most cited papers
- Verified
Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: A case-control study
Di Forti, M., Marconi, A., Carra, E., Fraietta, S., Trotta, A., Bonomo, M., Bianconi, F., Gardner-Sood, P., O'Connor, J., Russo, M., et al. (2015) · The Lancet Psychiatry
Cannabis and Cannabinoid ResearchSchizophrenia research and treatment
Cited by 588
- Verified
High-potency cannabis and the risk of psychosis
Di Forti, M., Morgan, C., Dazzan, P., Pariante, C., Mondelli, V., Marques, T. R., Handley, R., Luzi, S., Russo, M., Paparelli, A., et al. (2009) · British Journal of Psychiatry
Cannabis and Cannabinoid ResearchSchizophrenia research and treatment
Cited by 567
- Verified
The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment
Ashok, A. H., Marques, T. R., Jauhar, S., Nour, M. M., Goodwin, G. M., Young, A. H., & Howes, O. D. (2017) · Molecular Psychiatry
Bipolar Disorder and TreatmentSchizophrenia research and treatment
Cited by 546
- Verified
Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis
Mondelli, V., Ciufolini, S., Belvederi Murri, M., Bonaccorso, S., Di Forti, M., Giordano, A., Marques, T. R., Zunszain, P. A., Morgan, C., Murray, R. M., et al. (2015) · Schizophrenia Bulletin
Schizophrenia research and treatmentTryptophan and brain disorders
Cited by 286
- Verified
Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: The role of stress and of antipsychotic treatment
Mondelli, V., Dazzan, P., Hepgul, N., Di Forti, M., Aas, M., D'Albenzio, A., Di Nicola, M., Fisher, H., Handley, R., Marques, T. R., et al. (2010) · Schizophrenia Research
Stress Responses and CortisolSchizophrenia research and treatment
Cited by 278
- Verified
Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users
Di Forti, M., Iyegbe, C., Sallis, H., Kolliakou, A., Falcone, M. A., Paparelli, A., Sirianni, M., La Cascia, C., Stilo, S. A., Marques, T. R., et al. (2012) · Biological Psychiatry
Cannabis and Cannabinoid ResearchSchizophrenia research and treatment
Cited by 234
- Verified
Neuroinflammation in schizophrenia: meta-analysis of in vivo microglial imaging studies
Marques, T. R., Ashok, A. H., Pillinger, T., Veronese, M., Turkheimer, F. E., Dazzan, P., Sommer, I. E. C., & Howes, O. D. (2019) · Psychological Medicine
Schizophrenia research and treatmentNeuroinflammation and Neurodegeneration Mechanisms
Cited by 213
- Verified
Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis
Mondelli, V., Pariante, C. M., Navari, S., Aas, M., D'Albenzio, A., Di Forti, M., Handley, R., Hepgul, N., Marques, T. R., Taylor, H., et al. (2010) · Schizophrenia Research
Schizophrenia research and treatmentStress Responses and Cortisol
Cited by 144
- Verified
Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis
Aas, M., Dazzan, P., Mondelli, V., Toulopoulou, T., Reichenberg, A., Di Forti, M., Fisher, H. L., Handley, R., Hepgul, N., Marques, T., et al. (2011) · Psychological Medicine
Stress Responses and CortisolSchizophrenia research and treatment
Cited by 124
- Verified
Childhood maltreatment is associated with increased body mass index and increased C-reactive protein levels in first-episode psychosis patients
Hepgul, N., Pariante, C. M., Dipasquale, S., DiForti, M., Taylor, H., Marques, T. R., Morgan, C., Dazzan, P., Murray, R. M., & Mondelli, V. (2012) · Psychological Medicine
Child Abuse and TraumaSchizophrenia research and treatment
Cited by 112
- Verified · note
Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia
Sønderby, I. E., Gústafsson, Ó., Doan, N. T., Hibar, D. P., Martin-Brevet, S., Abdellaoui, A., Ames, D., Amunts, K., Andersson, M., Armstrong, N. J., et al. (2020) · Molecular Psychiatry
Genomic variations and chromosomal abnormalitiesGenetics and Neurodevelopmental Disorders
Cited by 66
- Verified
The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study
Onwordi, E. C., Whitehurst, T., Mansur, A., Statton, B., Berry, A., Quinlan, M., O’Regan, D. P., Rogdaki, M., Marques, T. R., Rabiner, E. A., et al. (2021) · Translational Psychiatry
Schizophrenia research and treatmentNeuroscience and Neuropharmacology Research
Cited by 55
- Verified
Effects of antipsychotics on cortisol, interleukin-6 and hippocampal perfusion in healthy volunteers
Handley, R., Mondelli, V., Zelaya, F., Marques, T., Taylor, H., Reinders, A. A. T. S., Chaddock, C., McQueen, G., Hubbard, K., Papadopoulos, A., et al. (2016) · Schizophrenia Research
Schizophrenia research and treatmentStress Responses and Cortisol
Cited by 42
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free